-+ 0.00%
-+ 0.00%
-+ 0.00%

Chardan Capital Maintains Buy on Immatics, Maintains $25 Price Target

Benzinga·11/24/2025 16:02:28
Listen to the news
Chardan Capital analyst Geulah Livshits maintains Immatics (NASDAQ:IMTX) with a Buy and maintains $25 price target.